XPRIZE Founder Diamandis Predicts Tech Giants Amazon, Apple, and Google Will Be Doctors of The Future

Strategists agree that big tech is disrupting healthcare, so how will clinical laboratories and anatomic pathology groups serve virtual healthcare customers? Visionary XPRIZE founder Peter Diamandis, MD, sees big tech as “the doctor of the future.” In an interview with Fast Company promoting his new book, “The Future Is Faster Than You Think,” Diamandis, who is the Executive Chairman of the XPRIZE Foundation, said that the healthcare industry is “phenomenally broken” and that Apple, Amazon,...

Innovator Hospitals Bring ICUs into the Info Age, Using New Design Approaches that involve Medical Laboratory Tests

By consolidating information, automating data collection, and harnessing new cloud computing technologies, doctors hope to silence the endless array of alarms and inject efficiency and personalization into the critical care experience Some healthcare experts believe it is time that intensive care units undergo a workflow redesign to improve the quality of care they deliver, while reducing or eliminating design elements that contribute to errors. Clinical laboratories have a stake in this...

St. Vincent Seton Specialty Hospital Improves Clinical Laboratory Test Utilization, LOS, and Patient Outcomes by Use of Cloud-based Business Intelligence System

Leadership and the medical laboratory team at this Indianapolis, Indiana-based specialty hospital implemented a clinical intelligence system delivered via the cloud Does clinical use of a business intelligence (BI) system give hospitals and their clinical laboratories a way to add more value to physicians and contribute to improved outcomes? If you ask the clinical laboratory team and leadership at one specialty hospital in the Midwest, their answer is a resounding “yes!” St. Vincent Seton...

IBM Invests $100 Million in Healthcare Informatics, but That is Not Unusual for IBM

Company will develop solutions for new reimbursement models, evidence-based care, and supporting health service delivery needs Earlier this fall, IBM Corporation (NYSE: IBM) announced plans to invest $100 million specifically to advance IBM capabilities in three key areas of healthcare informatics. That seemed like a big deal that might affect clinical pathology, since IBM is one of the information technology (IT) giants in the United States. However, Dark Daily editors made a surprising...
;